Autoimmune diseases are characterized by the loss of tolerance toward self-antigens and the induction of destructive immune responses leading to tissue damage. Most patients with autoimmune diseases are treated with immunosuppressive drugs that suppress the immune response in a non-specific fashion, which is inevitably accompanied by several side effects. Antigen-specific immunomodulation and patient-tailored therapies are likely to solve these issues and to elicit long-term protection against disease flares. This Viewpoint analyzes the potential use of DC for induction of antigen-specific tolerance in autoimmune disease settings.
Dendritic cells in tolerance induction for the treatment of autoimmune diseases / M. Rescigno. - In: EUROPEAN JOURNAL OF IMMUNOLOGY. - ISSN 0014-2980. - 40:8(2010 Aug), pp. 2119-2123. [10.1002/eji.201040474]
Dendritic cells in tolerance induction for the treatment of autoimmune diseases
M. Rescigno
2010
Abstract
Autoimmune diseases are characterized by the loss of tolerance toward self-antigens and the induction of destructive immune responses leading to tissue damage. Most patients with autoimmune diseases are treated with immunosuppressive drugs that suppress the immune response in a non-specific fashion, which is inevitably accompanied by several side effects. Antigen-specific immunomodulation and patient-tailored therapies are likely to solve these issues and to elicit long-term protection against disease flares. This Viewpoint analyzes the potential use of DC for induction of antigen-specific tolerance in autoimmune disease settings.File | Dimensione | Formato | |
---|---|---|---|
Rescigno-2010-European_Journal_of_Immunology.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
248.35 kB
Formato
Adobe PDF
|
248.35 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.